ストックスクリーナーアプリを入手
1.49
0.00%
0.00
アフターアワーズ：
1.50
0.01
+0.67%
前日終値:
$1.49
開ける：
$1.48
24時間の取引高:
172.87K
Relative Volume:
0.43
時価総額：
$82.92M
収益：
$69.23M
当期純損益:
$-33.10M
株価収益率:
-1.2627
EPS:
-1.18
ネットキャッシュフロー:
$-39.26M
1週間 パフォーマンス:
+0.68%
1か月 パフォーマンス:
+29.57%
6か月 パフォーマンス:
-16.29%
1年 パフォーマンス:
-44.40%
1日の値動き範囲:
$1.4461
$1.53
1週間の範囲:
$1.40
$1.66
52週間の値動き範囲:
$0.52
$5.0699
Neuronetics Inc Stock (STIM) Company Profile
STIM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.49 | 82.92M | 69.23M | -33.10M | -39.26M | -1.18 |
|
TMO
Thermo Fisher Scientific Inc
|
532.02 | 203.50B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
234.84 | 169.62B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
135.69 | 38.75B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.39 | 35.83B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
415.53 | 34.03B | 3.84B | 866.24M | 792.60M | 10.37 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-13 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | ダウングレード | BTIG Research | Buy → Neutral |
| 2021-10-13 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | 開始されました | BTIG Research | Buy |
| 2018-07-24 | 開始されました | Canaccord Genuity | Buy |
すべてを表示
Neuronetics Inc (STIM) 最新ニュース
Neuronetics Awards Stock Units to New Employee Bill Leonard - MSN
Neuronetics (NASDAQ:STIM) Is Making Moderate Use Of Debt - Simply Wall St
HighTower Advisors LLC Increases Stock Holdings in Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Neuronetics (STU:NRC) Future 3-5Y EPS without NRI Growth Ra - GuruFocus.com
Neuronetics Revamps TrakStar System, Streamlining Patient Data Management - MSN
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Neuronetics Grants Strategic 50,000 PRSU Inducement Award to Key New Employee - StockTitan
Neuronetics' SWOT analysis: merger impact on neurohealth stock By Investing.com - Investing.com Australia
Neuronetics Unveils Strategic Performance-Based Stock Awards Targeting Cash Flow Breakeven by 2025 - StockTitan
Neuronetics' SWOT analysis: merger impact on neurohealth stock - Investing.com
Neuronetics, Greenbrook TMS close transaction - Medical Buyer
Neuronetics Expands with Greenbrook TMS Acquisition - TipRanks
Madryn Provides Update on Holdings of Greenbrook TMS Inc. - The Manila Times
Neuronetics and Greenbrook TMS Announce Closing of Transaction - The Manila Times
Reviewing Stryker (NYSE:SYK) & Neuronetics (NASDAQ:STIM) - Defense World
Neuronetics' SWOT analysis: merger, market challenges shape TMS stock outlook - Investing.com Nigeria
Neuronetics (STU:NRC) 3-Year EPS without NRI Growth Rate : 9.40% (As of Sep. 2024) - GuruFocus.com
Neuronetics (STU:NRC) Profitability Rank : 1 (As of Sep. 2024) - GuruFocus.com
Greenbrook TMS Q3 Revenue Up 9% to $18.9M, Plans to Close 23 Centers Amid Merger - StockTitan
Transcranial Magnetic Stimulator Market Overall Study Report - openPR
GSA Capital Partners LLP Purchases 30,837 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Transcranial Magnetic Stimulator Market Future Business - openPR
FDA Clears NeuroStar's TMS Therapy for Adolescents with Major Depressive Disorder - MSN
Neuronetics to Showcase Neurohealth Innovations at Piper Sandler Healthcare Conference! - MSN
Greenbrook TMS Strategic Acquisition and Restructuring by Neuronetics - TipRanks
Neuronetics Announces Q3 2024 Financial Results and Greenbrook TMS Acquisition Approval - MSN
Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference - The Manila Times
Neuronetics to Present at Piper Sandler Healthcare Conference in December 2024 | STIM Stock News - StockTitan
Neuronetics Grants Inducement Awards to New Employees - MSN
Neuronetics Expands TMS Coverage, Enhancing Access for MDD Treatment - MSN
Neuronetics, Inc. (NASDAQ:STIM) Analysts Just Slashed Next Year's Revenue Estimates By 12% - Simply Wall St
Neuronetics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Need To Know: The Consensus Just Cut Its Neuronetics, Inc. (NASDAQ:STIM) Estimates For 2025 - Yahoo Finance
William Blair Decreases Earnings Estimates for Neuronetics - Defense World
Greenbrook TMS Acquisition by Neuronetics Approved - TipRanks
Neuronetics, Inc. (NASDAQ:STIM) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance
Neuronetics regains Nasdaq compliance with bid price By Investing.com - Investing.com Australia
CANNELL CAPITAL LLC Adjusts Stake in Neuronetics Inc - GuruFocus.com
Neuronetics Inc. (STIM) Quarterly 10-Q Report - Quartzy
Earnings call: Neuronetics reports revenue growth amidst strategic shifts By Investing.com - Investing.com Australia
Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates - MSN
Neuronetics regains Nasdaq compliance with bid price - Investing.com
Earnings call: Neuronetics reports revenue growth amidst strategic shifts - Investing.com
Neuronetics, Inc. (NASDAQ:STIM) Q3 2024 Earnings Call Transcript - Insider Monkey
Neuronetics announces inducement grant - Medical Buyer
Neuronetics Inc (STIM) 財務データ
収益
当期純利益
現金流量
EPS
Neuronetics Inc (STIM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| MACAN WILLIAM ANDREW | EVP, GC, CCO and CS |
Oct 08 '24 |
Sale |
0.82 |
1,541 |
1,264 |
402,792 |
0.42%
大文字化:
|
ボリューム (24 時間):